Concepedia

Proposal of pharmacogenetics-based warfarin dosing algorithm in Korean patients

Jung Ran Choi, Jeong-Oh Kim, Dae Ryong Kang, Seong-Ae Yoon, Jung-Young Shin, Xianghua Zhang, Mee Ork Roh, Hyung Joo Hong, Young-Pil Wang, Keon-Hyon Jo,

Journal of Human Genetics · 2011 · 41 citations · 21 references

DOIFull text

Open access

Concepts

References

21

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen

Elizabeth Sconce, Tayyaba Khan, Hilary Wynne et al. · Blood · 2005 · 947 citations · Full text

, , +17

A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin

Giovanna D’Andrea, Rosa D’Ambrosio, P Perna et al. · Blood · 2004 · 695 citations · Full text

, , +14

CYP4F2 genetic variant alters required warfarin dose

Michael D. Caldwell, Tarif Awad, Julie A. Johnson et al. · Blood · 2008 · 522 citations · Full text

, , +11

Common VKORC1 and GGCX polymorphisms associated with warfarin dose

Mia Wadelius, L Y Chen, Kate Downes et al. · The Pharmacogenomics Journal · 2005 · 467 citations

, , +13

Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups

Nita A. Limdi, Mia Wadelius, Larisa H. Cavallari et al. · Blood · 2010 · 370 citations · Full text

, , +16